{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:23:11Z","timestamp":1789132991694,"version":"build-2803163510"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250758-4\"><jats:title>Importance<\/jats:title><jats:p>Rural patients face unique barriers in obtaining high-quality cancer care. Research is lacking in determining whether these disparities translate to negative clinical outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250758-5\"><jats:title>Objective<\/jats:title><jats:p>To determine if there are differences in the rate of biochemical recurrence in prostate cancer between rural and urban men.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250758-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study used patient data that was abstracted from the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study, a population-based cohort that prospectively followed patients with newly diagnosed prostate cancer from the Rapid Case Ascertainment system of the North Carolina Central Cancer Registry from January 1, 2011, to June 30, 2013. Patients were identified who had received either surgery or radiation within 1 year of diagnosis. Data were analyzed from January 2011 to December 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250758-7\"><jats:title>Exposure<\/jats:title><jats:p>Patients were categorized as rural or urban using the Rural-Urban Continuum Code.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250758-8\"><jats:title>Main Outcome and Measures<\/jats:title><jats:p>Recurrence was determined by prostate-specific antigen testing. Demographic differences between rural and urban patients were assessed using 2-sample independent <jats:italic>t<\/jats:italic> test and \u03c7<jats:sup>2<\/jats:sup> test. Prostate cancer recurrence was analyzed using Cox proportional hazard models.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250758-9\"><jats:title>Results<\/jats:title><jats:p>A total of 778 patients were included with a median (IQR) follow-up of 4.6 (2.0 to 6.9) years and a mean (SD) age of 63 (7.4) years. Additionally, 213 were Black men (27.4%), 565 were White men (72.6%), 350 were Medicare insured (45.1%), 324 had an income ranging from $40\u202f000 to $90\u202f000 (43.1%), 370 were a National Comprehensive Cancer Network (NCCN) intermediate risk group (47.6%), 449 were treated with radical prostatectomy (57.7%), and 690 were in good to excellent health (88.7%) with 191 living in a rural setting (24.6%). On univariable analysis, rural residence (hazard ratio [HR], 2.19 [95% CI, 1.38 to 3.46]; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), NCCN risk group (HR, 4.13 [95% CI, 2.25 to 7.57]; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), and having had fewer than 12 biopsies (HR, 1.70 [95% CI, 1.08 to 2.67]; <jats:italic>P<\/jats:italic>\u2009=\u2009.02) were significantly associated with biochemical recurrence. On multivariable analysis adjusted for location of residence, marital status, overall health, number of cores biopsied, NCCN risk group, and treatment type, rural residence was significantly associated with recurrence (HR, 1.74 [95% CI, 1.07 to 2.82]; <jats:italic>P<\/jats:italic>\u2009=\u2009.03), while radiation therapy was inversely associated with recurrence (HR, 0.51 [95% CI, 0.31 to 0.85]; <jats:italic>P<\/jats:italic>\u2009=\u2009.01).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250758-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cohort study of patients with newly diagnosed prostate cancer, rural patients with prostate cancer had higher rates of biochemical recurrence. The etiology of this disparity is unclear but is likely multifactorial. Factors that may play a role include socioeconomic status, delay and disruptions in care, and access to multidisciplinary cancer care.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.26912","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:30:35Z","timestamp":1754667035000},"page":"e2526912","source":"Crossref","is-referenced-by-count":6,"title":["Rural and Urban Differences in Prostate Cancer Recurrence"],"prefix":"10.1001","volume":"8","author":[{"given":"Julia B.","family":"Balmaceda","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Kansas Medical Center, Kansas City"},{"name":"Department of Population Health, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Kane","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Usinger","sequence":"additional","affiliation":[{"name":"Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglei","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"17","key":"zoi250758r1","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1200\/JCO.2008.21.1680","article-title":"American society of clinical oncology policy statement: disparities in cancer care.","volume":"27","author":"Goss","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi250758r2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3322\/caac.21801","article-title":"Social determinants of health and US cancer screening interventions: a systematic review.","volume":"73","author":"Korn","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi250758r3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/canjclin.54.2.78","article-title":"Cancer disparities by race\/ethnicity and socioeconomic status.","volume":"54","author":"Ward","year":"2004","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"zoi250758r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.25291","article-title":"Disparities in travel-related barriers to accessing health care from the 2017 national household travel survey.","volume":"6","author":"Labban","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi250758r5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.amjmed.2023.02.008","article-title":"Environmentally mediated health disparities.","volume":"136","author":"Howarth","year":"2023","journal-title":"Am J Med"},{"key":"zoi250758r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2021.101995","article-title":"Exploring the influence of rural residence on uptake of organized cancer screening: a systematic review of international literature.","volume":"74","author":"Walji","year":"2021","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"zoi250758r7","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/j.amepre.2021.05.021","article-title":"Urban-rural variations in quality of care among patients with cancer in California.","volume":"61","author":"Parikh-Patel","year":"2021","journal-title":"Am J Prev Med"},{"issue":"5","key":"zoi250758r8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/cncr.27840","article-title":"Rural-urban disparities in health status among US cancer survivors.","volume":"119","author":"Weaver","year":"2013","journal-title":"Cancer"},{"issue":"8","key":"zoi250758r9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1200\/OP.23.00547","article-title":"Differences in rural versus urban patients with prostate cancer in diagnosis and treatment: an analysis of a population-based cohort.","volume":"20","author":"Shen","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"zoi250758r10","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ijrobp.2020.11.055","article-title":"Influence of geography on prostate cancer treatment.","volume":"109","author":"Tang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"zoi250758r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1255","article-title":"Association of sociodemographic and health-related factors with receipt of nondefinitive therapy among younger men with high-risk prostate cancer.","volume":"3","author":"Bagley","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi250758r12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv134","article-title":"Challenges and opportunities in measuring cancer recurrence in the United States.","volume":"107","author":"Warren","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"zoi250758r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy.","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi250758r15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1200\/JCO.2023.41.6_suppl.393","article-title":"Long-term rates of biochemical recurrence after primary external beam radiation therapy (EBRT) for prostate cancer.","volume":"41","author":"Escobar","year":"2023","journal-title":"J Clin Oncol"},{"issue":"16","key":"zoi250758r16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e17112","article-title":"Biochemical recurrence (BCR) and outcomes in patients (pts) with prostate cancer (PC) following radical prostatectomy (RP).","volume":"41","author":"Khan","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi250758r17","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.21873\/anticanres.17129","article-title":"Predictive factors for early biochemical recurrence following robot-assisted radical prostatectomy.","volume":"44","author":"Mitsunari","year":"2024","journal-title":"Anticancer Res"},{"issue":"2","key":"zoi250758r18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41391-023-00727-6","article-title":"Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men.","volume":"27","author":"Epstein","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"zoi250758r19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/COC.0000000000000093","article-title":"Do sociodemographic factors influence outcome in prostate cancer patients treated with external beam radiation therapy?","volume":"39","author":"Movsas","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"zoi250758r20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.eururo.2016.03.010","article-title":"The effect of salvage radiotherapy and its timing on the health-related quality of life of prostate cancer patients.","volume":"70","author":"van Stam","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"zoi250758r21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/cancers13020244","article-title":"Functional outcomes after local salvage therapies for radiation-recurrent prostate cancer patients: a systematic review.","volume":"13","author":"Abufaraj","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"20","key":"zoi250758r23","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1200\/JCO-25-00007","article-title":"Systemic therapy in patients with metastatic castration-resistant prostate cancer: ASCO Guideline Update.","volume":"43","author":"Garje","year":"2025","journal-title":"J Clin Oncol"},{"issue":"8","key":"zoi250758r24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaoncol.2016.6744","article-title":"Comparison of patient report and medical records of comorbidities: results from a population-based cohort of patients with prostate cancer.","volume":"3","author":"Ye","year":"2017","journal-title":"JAMA Oncol"},{"issue":"7624","key":"zoi250758r25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"zoi250758r26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1200\/OP.20.00174","article-title":"Closing the rural cancer care gap: three institutional approaches.","volume":"16","author":"Levit","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"zoi250758r28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","article-title":"Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.","volume":"177","author":"Cookson","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"zoi250758r29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"zoi250758r30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1513\/AnnalsATS.201606-469OC","article-title":"Residence in rural areas of the united states and lung cancer mortality: disease incidence, treatment disparities, and stage-specific survival.","volume":"14","author":"Atkins","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"zoi250758r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101505","article-title":"Rural-urban disparities in mortality and geriatric assessment among older adults with cancer: the cancer and aging resilience evaluation (CARE) registry.","volume":"14","author":"Fowler","year":"2023","journal-title":"J Geriatr Oncol"},{"issue":"5","key":"zoi250758r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12246","article-title":"Racial and ethnic differences in rural-urban trends in 5-year survival of patients with lung, prostate, breast, and colorectal cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER).","volume":"5","author":"Lewis-Thames","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi250758r33","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/cam4.1382","article-title":"Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah.","volume":"7","author":"Hashibe","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"zoi250758r34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.amepre.2018.01.021","article-title":"Rural-urban disparities in stage of diagnosis among cancers with preventive opportunities.","volume":"54","author":"Zahnd","year":"2018","journal-title":"Am J Prev Med"},{"issue":"7","key":"zoi250758r35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/DCR.0b013e31828e15cb","article-title":"Geographical disparities of rectal cancer local recurrence and outcomes: a population-based analysis.","volume":"56","author":"Helewa","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"zoi250758r36","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/j.clbc.2016.07.006","article-title":"Adherence to needed adjuvant therapy could decrease recurrence rates for rural patients with early breast cancer.","volume":"16","author":"Xuan","year":"2016","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"zoi250758r37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/JU.0000000000000500","article-title":"Under treatment of prostate cancer in rural locations.","volume":"203","author":"Maganty","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"zoi250758r38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijrobp.2022.06.075","article-title":"Sociodemographic and clinical factors associated with radiation treatment nonadherence and survival among rural and nonrural patients with cancer.","volume":"116","author":"Morris","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"zoi250758r39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ijrobp.2015.12.008","article-title":"Association between treatment at a high-volume facility and improved survival for radiation-treated men with high-risk prostate cancer.","volume":"94","author":"Chen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"zoi250758r40","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/jnci\/djac030","article-title":"Rural-urban disparities in cancer outcomes: opportunities for future research.","volume":"114","author":"Bhatia","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"zoi250758r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2021.102541","article-title":"The effect of Medicaid expansion on Medicaid participation, payer mix, and labor supply in primary care.","volume":"80","author":"Neprash","year":"2021","journal-title":"J Health Econ"},{"issue":"8","key":"zoi250758r42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037705","article-title":"Exploration of rural physicians\u2019 lived experience of practising outside their usual scope of practice to provide access to essential medical care (clinical courage): an international phenomenological study.","volume":"10","author":"Konkin","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"zoi250758r43","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/s13187-023-02304-w","article-title":"It\u2019s not always easy: cancer survivorship care in primary care settings.","volume":"38","author":"Becevic","year":"2023","journal-title":"J Cancer Educ"},{"issue":"4","key":"zoi250758r44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.18553\/jmcp.2024.30.4.376","article-title":"Geographic disparity in the distribution of cancer clinical trials in the United States and the associated factors.","volume":"30","author":"Gu","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"zoi250758r13","unstructured":"Measures that are limited or not available in the data. National Cancer Institute. Accessed July 7, 2025. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/measures.html#:~:text=Neither%20SEER%20nor%20Medicare%20collect,recurrence%20through%20diagnosis%20codes%20only"},{"key":"zoi250758r22","unstructured":"Fasola? CE. The Cost of Cancer. Accessed July 19, 2025. https:\/\/treatcancer.com\/blog\/cost-of-cancer\/"},{"key":"zoi250758r27","unstructured":"Rural-Urban Continuum Codes. Accessed July 14, 2025. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837363\/balmaceda_2025_oi_250758_1753980313.98081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:30:36Z","timestamp":1754667036000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.26912","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}